EDSA Stock Analysis: Buy, Sell, or Hold?
EDSA - Edesa Biotech, Inc. Common Shares
$2.77
0.01 (0.36%)
▲
5d:
+7.78%
30d:
-31.27%
90d:
-48.22%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Dec 11, 2026
Get Alerted When EDSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: EDSA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: EDSA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: EDSA is currently trading at $2.77, which is considered oversold relative to its 30-day fair value range of $2.96 to $4.12.
Technical Outlook: Technically, EDSA is in a strong downtrend. Immediate support is located at $2.52, while resistance sits at $3.56.
Market Sentiment: EDSA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.33 (+489.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EDSA is in a strong downtrend. Immediate support is located at $2.52, while resistance sits at $3.56.
Market Sentiment: EDSA scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.33 (+489.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.96 -
$4.12
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 489.6% below Wall St target ($16.33)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.96 -
$4.12
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.52
Resistance Level
$3.56
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.34
Wall Street Target
$16.33
(+489.6%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: October 23, 2026 6:07 PM ET
Data refreshes hourly during market hours. Next update: 7:07 PM
Data refreshes hourly during market hours. Next update: 7:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EDSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 58 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 75 BUY |
